Alignment Healthcare ALHC
Alignment Healthcare, Inc. · Nasdaq · Hospital & Medical Service Plans
$8.18+1.61%close on Oct. 28, 2026 · volume 4.6M · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Oct. 6, 2026 | Hyong Kim Chief Medical Officer | Sold | 32,479 | $8.30 | $269,576 |
| Sept. 17, 2026 | Joseph S. Konowiecki EVP, Corporate Affairs, director | Sold | 23,511 | $8.61 | $202,430 |
| Sept. 14, 2026 | John E. Kao Chief Executive Officer, director · indirect | Sold 10b5-1 plan | 27,400 | $13.00 | $356,200 |
| Sept. 11, 2026 | Dawn Christine Maroney President | Sold | 122,707 | $12.68 | $1.56 million |
| Sept. 11, 2026 | John E. Kao Chief Executive Officer, director | Sold 10b5-1 plan | 385,270 | $12.68 | $4.89 million |
| Sept. 10, 2026 | John E. Kao Chief Executive Officer, director · indirect | Sold 10b5-1 plan | 172,600 | $12.96 | $2.24 million |
| Aug. 14, 2026 | Dawn Christine Maroney President | Sold 10b5-1 plan | 5,000 | $14.00 | $70,000 |
| Aug. 10, 2026 | John E. Kao Chief Executive Officer, director · indirect | Sold 10b5-1 plan | 298,000 | $13.88 | $4.14 million |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 14 →Regulation FD disclosure